For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.60 in the prior trading day, PMV Pharmaceuticals Inc (NASDAQ: PMVP) closed at $1.58, down -1.25%. In other words, the price has decreased by -$1.25 from its previous closing price. On the day, 1.04 million shares were traded. PMVP stock price reached its highest trading level at $1.6199 during the session, while it also had its lowest trading level at $1.56.
Ratios:
Our goal is to gain a better understanding of PMVP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.22 and its Current Ratio is at 19.22. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on May 13, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On April 12, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $5.
On December 27, 2023, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $7.Ladenburg Thalmann initiated its Buy rating on December 27, 2023, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 22 ’23 when ORBIMED ADVISORS LLC sold 87,786 shares for $2.23 per share. The transaction valued at 195,763 led to the insider holds 0 shares of the business.
Jalota Deepika sold 4,104 shares of PMVP for $27,168 on Sep 15 ’23. The Chief Development Officer now owns 29,946 shares after completing the transaction at $6.62 per share. On Sep 15 ’23, another insider, Alland Leila, who serves as the Chief Medical Officer of the company, sold 6,291 shares for $6.62 each. As a result, the insider received 41,646 and left with 45,909 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PMVP now has a Market Capitalization of 81401288 and an Enterprise Value of -118527792.
Stock Price History:
Over the past 52 weeks, PMVP has reached a high of $7.64, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is 0.18%, while the 200-Day Moving Average is calculated to be -15.91%.
Shares Statistics:
The stock has traded on average 400.15K shares per day over the past 3-months and 333880 shares per day over the last 10 days, according to various share statistics. A total of 51.45M shares are outstanding, with a floating share count of 43.78M. Insiders hold about 15.03% of the company’s shares, while institutions hold 73.55% stake in the company. Shares short for PMVP as of 1722384000 were 1072344 with a Short Ratio of 2.72, compared to 1719532800 on 2239604. Therefore, it implies a Short% of Shares Outstanding of 1072344 and a Short% of Float of 2.4400001000000002.
